Laboratory tests of the anti-inflammatory action of drugs are based upon the suppression of some feature of the inflammatory response such as the migration of leucocytes, changes in blood flow, and vascular permeability, or the formation of granulation tissue and oedema. The weight of granulation tissue formed and the effects of drugs in suppressing it are the basis of the granuloma pouch test (Selye, 1953) and techniques employing the implantation of cotton pellets (Meier, Schuler, and Desaulles, 1950) , polyvinyl sponges (Boucek and Noble, 1955) , and other irritant materials. These techniques, and those which rely on the measurement of oedematous tissue swelling after the injection of irritants such as carrageenan, dextran, ovalbumin, formalin, etc., fail to separate the relative contributions of fluid and cellular exudation to the inflammatory reaction.
We have attempted to obtain this important information by implanting subcutaneously in the rat polyurethane foam cubes impregnated with an irritant. Such implants can be recovered after various intervals and processed in different ways for separate analysis of the fluid exudate and the infiltrating cells. In previous studies in which pieces of foam have been implanted subcutaneously in experimental animals it has been the irritant nature ofthe foam itselfwhich has provoked an inflammatory response and the interest Accepted for publication October 24, 1974. Correspondence to: Professor H. L. F. Currey. in these models has been largely centred upon the later, fibrotic, stages of the inflammatory reaction (Bole and Heath, 1967; Kaltiala and Heikkinen, 1971) . This report describes the effects of a variety of anti-inflammatory agents, commonly used in the treatment of rheumatic diseases, on the cellular and fluid phases of the inflammatory response to polyurethane cubes impregnated with heat-killed Mycobacterium tuberculosis.
Materials and methods

ANIMALS
Female Wistar or Sprague-Dawley rats weighing 150 to 250 g were used. Unless otherwise specified, each test group contained 8 animals.
PREPARATION OF CUBES
Polyurethane foam (Dunlopillo grade D12, Dunlop) was cut into cubes measuring slightly less than 1 cm3 and weighing 17 mg. Some of the cubes were then impregnated with heat-killed M. tuberculosis (TBC) (Tuberculin Section, Ministry of Agriculture, Fisheries and Food) by immersing and compressing them in an aqueous suspension of TBC (0 5 mg/ml) followed by drying overnight at 37°C (to constant weight). Each cube then contained approximately 0-33 mg dry TBC, and microscopical examination of suitably stained sections showed this to be distributed evenly through the cube. Before implantation cubes were Assessment ofanti-inflammatory drugs 327 sterilized in ethylene oxide. Control (nonimpregnated) cubes were processed similarly except that the TBC were omitted.
IMPLANTATION OF CUBES
Under ether anaesthesia and using a sterile technique, cubes were implanted (one into each flank) through a dorsal midline incision. Each animal received an intraperitoneal injection of 20 mg chloramphenicol to prevent bacterial infection.
ASSESSMENT OF INFLAMMATORY FLUID EXUDATE
When cubes were removed, care was taken not to squeeze out any of the contained fluid. Cubes were then dried at 37°C overnight (to constant weight). The difference between the initial and final dry weight of each cube was recorded as the 'dry weight gain'. Preliminary studies in which rats were implanted with a TBC-impregnated cube in one flank and a nonimpregnated cube on the opposite side established that there was a reproducible and progressive daily increase in the dry weight gain of the irritant implant, while the dry weight gain of the nonirritant cubes remained relatively constant for the first 6 days ( Fig. 1 ). This consideration led to the choice of 5 days for the duration of the experiments described below. Further preliminary studies employing trypsinization and separate analysis of the cellular and fluid contents had established that on day +5 cells accounted for only about 12-5 % ofthe dry weight gain in the impregnated cube, and for about 2-5 % in the nonirritant implants.
ASSESSMENT OF INFLAMMATORY CELLULAR EXUDATE
On the fifth day after implantation, cubes complete with overlying skin and underlying body wall were removed, fixed in formol-saline, and embedded in wax. 5 ,um sections were cut through the central part of each cube and were stained with haematoxylin and eosin. A calibrated eyepiece was used to measure the depth of cellular invasion from the edge of the cube at three points on the superficial surface, three points on the deep surface, and two points on each of two remaining surfaces. The mean of these ten measurements gave the 'depth of cell invasion' for each cube. Preliminary experiments, similar to those described above, had indicated the progressive changes in this measurement after implantation ( Fig. 2 ) and had shown that there was a marked difference between the control 37-5
69-3 ± 1-9: Groups of rats (8 in each group) were given one of the drugs in the range of doses shown in Table I . Each rat was implanted on day 0 with an impregnated cube into either flank and all cubes were removed on day +5. Considerations regarding the duration of treatment that may be necessary to produce an antiinflammatory effect with some of these drugs led us to administer sodium aurothiomalate, hydroxychloroquine, and D-penicillamine from day -10 to day +4, and the remaining drugs from day 0 to day +4. Table I and Fig. 3 show the results. The magnitude of the anti-inflammatory effect achieved is indicated by comparing these figures with those in Fig. 1 . Control (nonimpregnated) cubes were not included in this experiment, but preliminary testing had established that neither azathioprine nor phenylbutazone given in daily doses of 200 mg/kg produced significant reduction in the weight of nonimpregnated cubes. In the doses tested, sodium aurothiomalate and hydroxychloroquine had no effect on dry weight gain, while D-penicillamine produced a significant reduction only at a daily dose of 100 mg/kg (with no significant effect at doses above and below this level). By contrast, phenylbutazone, azathioprine, aspirin, cyclophosphamide, and prednisolone all caused a progressive reduction in dry weight gain with increasing daily doses. Fig. 3 ). The regression coefficients reveal parallelism of the dose-response 'line of best fit' for azathioprine, aspirin, and cyclophosphamide; by contrast, phenylbutazone has a much shallower dose-response line and prednisolone a steeper line. Since there was a marked difference between the regression coefficient for phenylbutazone (-8 96) and the regression coefficients for azathioprine, aspirin, and cyclophosphamide (all in the region of -30), the effect of phenylbutazone was investigated again using a different range of daily dose (5, 10, 20, and 40 mg/kg). This second experiment revealed an almost identical regression coefficient of -8-72. Some measure of the relative potency of the effective drugs, when tested in this way, can be obtained by studying Fig. 3 . nated cubes implanted, one in either flank, and received the highest doses of the drugs according to the regimen shown in Table I . Five days after implantation sections of each cube (2 from each animal), together with the surrounding tissues, were prepared for microscopical examination and the mean depth of penetration of invading cells was assessed (see Methods). Fig. 4 shows the appearance of a TBC-impregnated cube on day +5 from a control rat which had not received any drug. Over 95 % of the infiltrating cells consist of neutrophil polymorphs. This ingrowth of cells is absent from a similarly treated but nonimpregnated cube (Fig. 5 ). This experiment thus tested the ability of the various drugs to suppress the cellular component ofan acute inflammatory reaction attributable to the impregnated irritant (TBC). Table III and Fig. 6 show the results. Compared with the untreated controls, all the treated groups showed a significant reduction in the depth of cell infiltration. This includes three drugs, sodium aurothiomalate, hydroxychloroquine, and D-penicillamine, which (at the maximum dosage tested) failed to influence the fluid phase of this inflammatory .0-0*9-E 0-8. . Further, among the other drugs tested, the orders of ranking for degree of inhibition of cellular infiltration (Fig. 5) and that for inhibition of dry weight gain (maximum doses in Fig. 3 ) show clear differences.
EFFECT OF VARIOUS DRUGS ON INFLUX OF INFLAMMATORY CELLS INTO CUBES IMPREG-
Discussion
The particular type ofpolyurethane foam used in these experiments is biologically relatively inert. After subcutaneous implantation in the rat it fills with 'wound juice', then (judged by the measures applied here) the implant provokes no inflammatory reaction until the 7th day, when granulation tissue begins to grow into it. In a sense, therefore, these cubes provide an inert matrix within which an inflammatory response can be provoked. Our continuing interest in this model is based on preliminary evidence that it provides a practical means of separately harvesting the fluid and cellular components of the inflammatory reaction for detailed studies. The present report concerns only two relatively crude measures applied to the model-dry weight gain and depth of cellular infiltration-selected because of their simplicity and reproducibility. Studies on fluid expressed from 'wet' cubes have established that the dry weight gain is largely a measure of protein in the fluid exudate, while the depth of infiltrating cells has been shown to reflect the numbers of cells actually in the cube. The inflammatory response studied here was acute and the very high proportion of neutrophil polymorphs present made differential cell counts uninformative.
The results reported have shown that the fluid phase of this acute inflammatory response to the presence of dead TBC is reduced by treatment with phenylbutazone, azathioprine, aspirin, cyclophosphamide, and prednisolone, but is not affected by the administration of sodium aurothiomalate, hydroxychloroquine, or D-penicillamine (apart from one dosage level with this latter drug). By contrast, all these drugs, including sodium aurothiomalate, hydroxychloroquine, and D-penicillamine, suppress the invasion of inflammatory cells into the sponges. These findings support the concept that the factors which mediate the fluid phase of the inflammatory exudate are probably independent ofthe factors which are concerned with the number of cells which ultimately appear in the inflammatory lesion; they also indicate that the degree of suppression of the fluid phase of inflammation by a particular anti-inflammatory drug may not be paralleled by the degree of suppression of the cellular phase. These observations stress the importance of using techniques which can separately measure the fluid and cellular phases of inflammation when carrying out assays of antiinflammatory drugs.
In a previous study, Vernon-Roberts, Jessop, and Dore (1973) found that sodium aurothiomalate suppressed both the fluid and cellular phases of the inflammatory response studied by the cotton pellet technique, whereas in the present study sodium aurothiomalate suppressed the cellular exudate alone. The disparity in these findings may relate to the relatively mild inflammatory response to the nonimpregnated cotton pellet, evidenced by the predominance ofmacrophages (over 90 %) in the exudate 4 days after implantation; by contrast, the present studies concerned a marked inflammatory reaction to a more potent irritant, evidenced by the predominance of neutrophil polymorphs (over 95 %). Further studies may therefore show that it is necessary to use inflammatory stimuli of varying intensities when assessing the actions of anti-inflammatory drugs.
The regression coefficients relating the doses of azathioprine, aspirin, and cyclophosphamide to dry weight gain of the cubes revealed parallelism of the dose-response relationships of these drugs and could suggest a close similarity in their mechanism of action in suppressing the fluid phase of inflammation. By contrast, the different coefficients for phenylbutazone and prednisolone indicate that the mechanism of action of these two drugs may differ from each other and from that of the other drugs investigated.
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